多巴胺对非进行性神经损伤后运动恢复与训练的影响:系统综述
该系统综述检索PubMed至2018年4月,纳入26篇关于非进行性神经损伤(如脑瘫、卒中、脊髓损伤、创伤性脑损伤)患者使用多巴胺能药物或评估多巴胺传递基因变异对运动恢复或学习影响的研究。证据提示脑损伤可能降低多巴胺传递,左旋多巴可能对卒中后运动结局有积极影响,但证据不确凿或不一致;多巴胺传递相关基因的个体差异可能影响神经康复中对运动技能训练的反应。
要点
- 左旋多巴可能改善卒中后运动结局,但证据不确凿或不一致。
- 脑损伤可能降低多巴胺传递,影响运动恢复。
- 多巴胺相关基因变异可能影响运动训练反应及药物增强效果。
核心结论
- 证据提示脑损伤可能降低多巴胺传递,左旋多巴可能对卒中后运动结局有积极影响,但证据不确凿或不一致。
- 多巴胺传递相关基因的个体变异可能影响神经康复中运动技能训练的反应及多巴胺能药物或干预的增强效果。
研究设计与样本
- 系统综述,检索PubMed至2018年4月,纳入英文文章,研究对象为非进行性神经损伤(如脑瘫、卒中、脊髓损伤、创伤性脑损伤)患者,需包含定量运动结局及多巴胺能系统或药物评估。
- 检索得到237篇文章,最终纳入26篇符合所有纳入/排除标准的文章。
主要发现
- 绝大多数文章与卒中后使用左旋多巴相关;也有数项研究评估不同药物和/或针对创伤性脑损伤、脊髓损伤或脑瘫个体。
- 证据提示脑损伤可能降低多巴胺传递。
- 左旋多巴可能对卒中后运动结局有积极影响,但证据不确凿或不一致。
- 多巴胺传递相关基因的个体变异可能影响神经康复中运动技能训练的反应及多巴胺能药物或干预的增强程度。
临床怎么用
- 对于卒中后运动恢复,可考虑左旋多巴的潜在积极影响,但需认识到证据不确凿或不一致。
- 在神经康复中制定运动训练方案时,可关注多巴胺传递相关基因变异的个体差异对训练反应的可能影响。
局限性
- 证据不确凿或不一致,主要集中于卒中后左旋多巴使用,其他神经损伤研究较少。
- 需要更严格的左旋多巴和多巴胺能药物在卒中及其他神经损伤中的安全性和有效性研究,包括基因分析。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The strong link between dopamine and motor learning has been well-established in the animal literature with similar findings reported in healthy adults and the elderly. OBJECTIVE: We aimed to conduct the first, to our knowledge, systematic review of the literature on the evidence for the effects of dopaminergic medications or genetic variations in dopamine transmission on motor recovery or learning after a nonprogressive neurological injury. METHODS: A PubMed search was conducted up until April 2018 for all English articles including participants with nonprogressive neurological injury such as cerebral palsy, stroke, spinal cord injury, and traumatic brain injury; quantitative motor outcomes; and assessments of the dopaminergic system or medications. RESULTS: The search yielded 237 articles, from which we identified 26 articles meeting all inclusion/exclusion criteria. The vast majority of articles were related to the use of levodopa poststroke; however, several studies assessed the effects of different medications and/or were on individuals with traumatic brain injury, spinal cord injury or cerebral palsy. CONCLUSIONS: The evidence suggests that a brain injury can decrease dopamine transmission and that levodopa may have a positive effect on motor outcomes poststroke, although evidence is not conclusive or consistent. Individual variations in genes related to dopamine transmission may also influence the response to motor skill training during neurorehabilitation and the extent to which dopaminergic medications or interventions can augment that response. More rigorous safety and efficacy studies of levodopa and dopaminergic medications in stroke and particularly other neurological injuries including genetic analyses are warranted.
引用
- Bradley CL, Damiano DL. Effects of Dopamine on Motor Recovery and Training in Adults and Children With Nonprogressive Neurological Injuries: A Systematic Review. Neurorehabil Neural Repair. 2019. PMID: 30913975. doi:10.1177/1545968319837289
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。